This observation aligns with clinical findings of heightened MS4A4A expression across multiple brain regions in human AD patients.[40] We then profiled its presence across various brain regions in WT mice from postnatal day 1 (P1) to postnatal day 84 (P84). Here, MS4A4A is linked to Alzheimer disease.